803595556	803595556	CD	B-NP	O
|	|	NN	I-NP	O
SSMC	SSMC	NN	I-NP	O
|	|	NN	I-NP	O
38332824	38332824	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1692060	1692060	CD	B-NP	O
|	|	CC	I-NP	O
4/10/2007	4/10/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/6/2007	2/6/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
TAPLIN	TAPLIN	NNP	B-NP	O
,	,	,	O	O
GERALDO	GERALDO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
REASON	REASON	NNP	I-NP	O
FOR	FOR	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Aerts	Aerts	NNP	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
transfer	transfer	NN	I-NP	O
from	from	IN	B-PP	O
Perel	Perel	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Bawany	Bawany	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
carotid	carotid	NN	B-NP	O
stenosis	stenosis	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
endarterectomies	endarterectomy	NNS	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
strokes	stroke	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
Arive	Arive	NNP	B-NP	O
Orro	Orro	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
embolic	embolic	JJ	I-NP	O
strokes	stroke	NNS	I-NP	O
after	after	IN	B-PP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
strokes	stroke	NNS	I-NP	O
including	include	VBG	B-PP	O
:	:	:	O	O
Echo	Echo	NN	B-NP	O
with	with	IN	B-PP	O
bubble	bubble	NN	B-NP	O
study	study	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
PFO	PFO	NN	B-NP	B-protein
or	or	CC	O	O
intraventricular	intraventricular	JJ	B-NP	O
clot	clot	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
transesophageal	transesophageal	JJ	I-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
CRP	CRP	NN	B-NP	B-protein
and	and	CC	I-NP	O
ESR	ESR	NN	I-NP	B-protein
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
vasculitis	vasculitis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
nonrevealing	nonrevealing	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
niacin	niacin	NN	B-NP	B-protein
given	give	VBN	B-VP	I-protein
her	her	PRP$	B-NP	I-protein
elevated	elevated	JJ	I-NP	I-protein
lipoprotein	lipoprotein	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
found	find	VBN	B-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
multiple	multiple	JJ	I-NP	O
CVAs	CVA	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
9/18/07	9/18/07	CD	B-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/3/07	3/3/07	CD	B-NP	O
,	,	,	O	O
Physical	Physical	NNP	B-NP	O
Therapy	Therapy	NNP	I-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
bedside	bedside	NN	I-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
her	her	PRP	B-NP	O
unresponsive	unresponsive	JJ	B-ADJP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
210/120	210/120	CD	B-NP	O
.	.	.	O	O

Clonidine	Clonidine	NN	B-NP	O
0.2	0.2	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
remained	remain	VBD	B-VP	O
elevated	elevated	JJ	B-ADJP	O
at	at	IN	B-PP	O
200/100	200/100	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
at	at	IN	B-PP	O
Sgalls	Sgalls	NNP	B-NP	O
Enbri	Enbri	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
episode	episode	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
remember	remember	VB	I-VP	O
the	the	DT	B-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
focal	focal	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
or	or	CC	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
sensation	sensation	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
vision	vision	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
URI	URI	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
or	or	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

Head	Head	JJ	B-NP	O
CT	CT	NN	I-NP	O
at	at	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
reportedly	reportedly	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
left	left	JJ	I-NP	O
PCA	PCA	NN	I-NP	O
distribution	distribution	NN	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

Brain	Brain	NNP	B-NP	O
MRI	MRI	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
tiny	tiny	JJ	B-NP	O
foci	focus	NNS	I-NP	O
of	of	IN	B-PP	O
restricted	restricted	JJ	B-NP	O
diffusion	diffusion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	B-DNA
left	left	JJ	I-NP	I-DNA
frontal	frontal	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
could	could	MD	B-VP	O
indicate	indicate	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
acute	acute	JJ	I-NP	O
embolic	embolic	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

Extensive	Extensive	JJ	B-NP	O
periventricular	periventricular	JJ	I-NP	O
white	white	JJ	I-NP	O
matter	matter	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
left	left	JJ	I-NP	O
PCA	PCA	NN	I-NP	O
infarct	infarct	NN	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
.	.	.	O	O

MRA	MRA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
MRI	MRI	NN	I-NP	O
8/29/07	8/29/07	CD	I-NP	O
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
focal	focal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
ICA	ICA	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
small	small	JJ	I-NP	O
thrombus	thrombus	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
right	right	JJ	I-NP	O
ICA	ICA	NN	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
,	,	,	O	O
Neurology	Neurology	NNP	B-NP	O
,	,	,	O	O
Renal	Renal	NNP	B-NP	O
and	and	CC	O	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
consultations	consultation	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
severe	severe	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
there	there	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
and	and	CC	I-NP	O
headache	headache	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
,	,	,	O	O
Motrin	Motrin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
morphine	morphine	NN	B-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

Systolic	Systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
ranged	range	VBD	B-VP	O
between	between	IN	B-PP	O
117	117	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
220	220	CD	I-NP	I-DNA
.	.	.	O	O

Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
and	and	CC	O	O
during	during	IN	B-PP	O
that	that	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
topical	topical	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
,	,	,	I-NP	O
minoxidil	minoxidil	NN	I-NP	O
and	and	CC	I-NP	O
Norvasc	Norvasc	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
View	View	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
prior	prior	JJ	I-NP	O
medical	medical	JJ	I-NP	O
care	care	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
stroke	stroke	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
including	include	VBG	B-PP	O
carotid	carotid	NN	B-NP	O
stenosis	stenosis	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
carotid	carotid	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
fem-fem	fem-fem	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ax-fem	ax-fem	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
8/4	8/4	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Question	Question	NN	B-NP	O
of	of	IN	B-PP	O
dementia	dementia	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
in	in	IN	B-PP	O
10/6	10/6	CD	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
adrenal	adrenal	JJ	I-NP	O
adenoma	adenoma	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
adenoma	adenoma	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Osteoporosis	Osteoporosis	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
4/9	4/9	CD	B-NP	O
,	,	,	O	O
lymph	lymph	NN	B-NP	O
node	node	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
XRT	XRT	NN	I-NP	O
and	and	CC	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Question	Question	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Spinal	Spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
degenerative	degenerative	JJ	B-NP	O
disk	disk	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
laminectomy	laminectomy	NN	I-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Nicoderm	Nicoderm	NN	B-NP	O
patch	patch	NN	I-NP	O
7	7	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Morphine	Morphine	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
2-5	2-5	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.2-4h	q.2-4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Nitroglycerin	Nitroglycerin	NN	B-NP	O
2	2	CD	I-NP	O
inches	inch	NNS	I-NP	O
topically	topically	RB	B-ADVP	O
q.	q.	VBP	B-VP	O
6	6	CD	B-NP	O
h.	h.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Lasix	Lasix	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Catapres	Catapre	NNS	B-NP	B-protein
0.2	0.2	CD	B-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Levoxyl	Levoxyl	NN	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Minoxidil	Minoxidil	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Niaspan	Niaspan	RB	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
bedtime	bedtime	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Norvasc	Norvasc	RB	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Humulin	Humulin	NNP	B-NP	O
N	N	NNP	I-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Humulin	Humulin	NNP	B-NP	O
N	N	NNP	I-NP	O
5	5	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
bedtime	bedtime	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Ecotrin	Ecotrin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Wellbutrin	Wellbutrin	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
37.5	37.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Zetia	Zetia	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Humulin	Humulin	NNP	B-NP	O
R	R	NNP	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
a.c.	a.c.	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
several	several	JJ	B-NP	O
allergies	allergy	NNS	I-NP	O
documented	document	VBN	B-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
include	include	VBP	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
cause	cause	VBP	B-VP	O
tremor	tremor	NN	B-NP	O
and	and	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Percocet	Percocet	NNP	B-NP	O
causes	cause	VBZ	B-VP	O
an	an	DT	B-NP	O
itch	itch	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Codeine	Codeine	NN	B-NP	O
causes	cause	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Losartan	Losartan	NN	B-NP	O
causes	cause	VBZ	B-VP	O
shakiness	shakiness	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Tramadol	Tramadol	NN	B-NP	O
causes	cause	VBZ	B-VP	O
confusion	confusion	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
causes	cause	VBZ	B-VP	O
irritability	irritability	NN	B-NP	O
and	and	CC	I-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

NSAIDs	NSAID	NNS	B-NP	O
cause	cause	VBP	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Isosorbide	Isosorbide	NN	B-NP	O
dinitrate	dinitrate	NN	I-NP	O
causes	cause	VBZ	B-VP	O
headache	headache	NN	B-NP	O
and	and	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Fluvastatin	Fluvastatin	NN	B-NP	B-protein
causes	cause	VBZ	B-VP	O
myalgias	myalgia	NNS	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Histamine	Histamine	NN	B-NP	O
H2	H2	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
cause	cause	VBP	B-VP	O
possible	possible	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
causes	cause	VBZ	B-VP	O
elevated	elevated	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Enalapril	Enalapril	NNP	B-NP	O
causes	cause	VBZ	B-VP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
plus	plus	CC	I-NP	O
APAP	APAP	NN	I-NP	B-protein
causes	cause	VBZ	B-VP	O
hives	hive	NNS	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Gabapentin	Gabapentin	NN	B-NP	B-protein
causes	cause	VBZ	B-VP	O
lethargy	lethargy	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Latex	Latex	RB	B-ADJP	O
unknown	unknown	JJ	I-ADJP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Fluoxetine	Fluoxetine	NN	B-NP	O
increased	increase	VBD	B-VP	O
depression	depression	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Colon	Colon	NN	B-NP	O
polyps	polyp	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
divorced	divorce	VBN	I-VP	O
and	and	CC	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
secretary	secretary	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
smoked	smoke	VBD	B-VP	O
two	two	CD	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
50	50	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
in	in	IN	B-PP	O
10/6	10/6	CD	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	NNP	B-NP	O
Signs	Signs	NNP	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
was	be	VBD	B-VP	O
96.7	96.7	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
74	74	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
170/86	170/86	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
awake	awake	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
alert	alert	JJ	I-ADJP	O
,	,	,	O	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
pupils	pupil	NNS	B-NP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
cooperate	cooperate	VB	I-VP	O
with	with	IN	B-PP	O
visual	visual	JJ	B-NP	O
field	field	NN	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
carotid	carotid	NN	B-NP	O
bruits	bruit	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
carotid	carotid	NN	I-NP	O
upstrokes	upstroke	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
trace	trace	NN	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
knew	know	VBD	B-VP	O
her	her	PRP	B-NP	O
name	name	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Merton	Merton	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
S	S	NNP	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
5/3	5/3	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
knew	know	VBD	B-VP	O
the	the	DT	B-NP	O
president	president	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
spell	spell	VB	I-VP	O
world	world	NN	B-NP	O
backwards	backward	NNS	I-NP	O
and	and	CC	I-NP	O
forwards	forward	NNS	I-NP	O
correctly	correctly	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
could	could	MD	B-VP	O
identify	identify	VB	I-VP	O
presidents	president	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
name	name	VB	I-VP	O
a	a	DT	B-NP	O
pen	pen	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
watch	watch	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
salute	salute	VB	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
strength	strength	NN	I-NP	O
was	be	VBD	B-VP	O
5/5	5/5	CD	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
deltoids	deltoid	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
triceps	tricep	NNS	I-NP	O
were	be	VBD	B-VP	O
4/5	4/5	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
triceps	tricep	NNS	B-NP	O
4	4	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
5	5	CD	B-NP	O
,	,	,	O	O
biceps	bicep	VBZ	B-VP	O
4	4	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
5	5	CD	B-NP	O
bilaterally	bilaterally	RB	I-NP	O
.	.	.	O	O

Strength	Strength	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
4	4	CD	B-NP	I-protein
-	-	HYPH	B-PP	O
/	/	SYM	B-NP	O
5	5	CD	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
bilateral	bilateral	JJ	I-NP	O
hip	hip	NN	I-NP	O
flexors	flexor	NNS	I-NP	O
,	,	,	O	O
dorsi	dorsi	NNS	B-NP	O
and	and	CC	O	O
plantar	plantar	NN	B-NP	O
flexion	flexion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
hyperreflexia	hyperreflexia	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
biceps	bicep	NNS	I-NP	O
or	or	CC	O	O
her	her	PRP$	B-NP	O
patella	patella	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
right-sided	right-sided	JJ	I-NP	O
dysmetria	dysmetria	NN	I-NP	O
on	on	IN	B-PP	O
finger-nose-finger	finger-nose-finger	NN	B-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
was	be	VBD	B-VP	O
133	133	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.5	3.5	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
104	104	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
21	21	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
30	30	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
2.6	2.6	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
1.8	1.8	CD	B-NP	O
in	in	IN	B-PP	O
8/4	8/4	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
217	217	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
7.35	7.35	CD	B-NP	O
with	with	IN	B-PP	O
63	63	CD	B-NP	O
%	%	NN	I-NP	O
neutrophils	neutrophil	NNS	I-NP	O
,	,	,	O	O
26	26	CD	B-NP	O
%	%	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
monocytes	monocyte	NNS	I-NP	O
and	and	CC	O	O
6	6	CD	B-NP	O
%	%	NN	I-NP	O
eosinophils	eosinophil	NNS	I-NP	B-cell_type
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
34	34	CD	B-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
27	27	CD	B-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

Platelets	Platelet	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
503	503	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
509	509	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Albumin	Albumin	NNP	B-NP	O
was	be	VBD	B-VP	O
3.6	3.6	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
3	3	CD	B-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
75	75	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	RB	B-ADVP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
linear	linear	JJ	I-NP	O
opacity	opacity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
third	third	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lung	lung	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
scarring	scar	VBG	B-VP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
otherwise	otherwise	RB	B-ADVP	O
well	well	RB	B-ADJP	O
expanded	expand	VBN	I-ADJP	O
and	and	CC	O	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cardiomediastinal	cardiomediastinal	JJ	I-NP	O
contours	contour	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
size	size	NN	I-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
calcification	calcification	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arch	arch	NN	I-NP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
and	and	CC	O	O
mildly	mildly	RB	B-NP	O
tortuous	tortuous	JJ	I-NP	O
descending	descend	VBG	I-NP	O
aorta	aorta	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
3/6/07	3/6/07	CD	B-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
relaxation	relaxation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
10/6/07	10/6/07	CD	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
intracardiac	intracardiac	JJ	I-NP	O
shunt	shunt	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Holter	Holter	NNP	I-NP	O
monitor	monitor	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
that	that	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
short	short	JJ	I-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
SVT	SVT	NN	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
most	most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
tachycardias	tachycardia	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
DONE	DONE	VBP	B-VP	O
SINCE	SINCE	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Carotid	Carotid	NNP	B-NP	O
ultrasound	ultrasound	IN	B-PP	O
11/23/07	11/23/07	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
80-85	80-85	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
mid	mid	JJ	B-NP	O
right	right	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
hemodynamically	hemodynamically	RB	B-NP	O
significant	significant	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

MR	MR	NN	B-NP	B-protein
brain	brain	NN	I-NP	O
6/28/07	6/28/07	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
revealed	reveal	VBD	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Multifocal	Multifocal	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
cortical	cortical	JJ	I-NP	O
infarcts	infarct	NNS	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
ages	age	NNS	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
and	and	CC	I-NP	O
posterior	posterior	JJ	I-NP	O
circulations	circulation	NNS	I-NP	O
with	with	IN	B-PP	O
newly	newly	RB	B-NP	O
developed	develop	VBN	I-NP	O
foci	focus	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
infarct	infarct	NN	I-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
14	14	CD	I-NP	O
days	day	NNS	I-NP	O
days	day	NNS	I-NP	O
old	old	JJ	B-ADJP	O
that	that	WDT	B-NP	O
suggests	suggest	VBZ	B-VP	O
ongoing	ongoing	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
,	,	,	I-NP	O
aortic	aortic	JJ	I-NP	O
or	or	CC	I-NP	O
carotid	carotid	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
emboli	embolus	NNS	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Focal	Focal	JJ	B-NP	O
moderate	moderate	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
or	or	CC	I-NP	O
thrombus	thrombus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
right	right	JJ	I-NP	O
ICA	ICA	NN	I-NP	O
.	.	.	O	O

Cervical	Cervical	JJ	B-NP	O
CTA	CTA	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
further	further	RBR	B-ADVP	O
if	if	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
focal	focal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
subclavian	subclavian	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
vertebral	vertebral	JJ	B-NP	O
artery	artery	NN	I-NP	O
origin	origin	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
visualization	visualization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
mid	mid	JJ	I-NP	I-DNA
segment	segment	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nondominant	nondominant	JJ	I-NP	O
right	right	JJ	I-NP	O
vertebral	vertebral	JJ	I-NP	O
artery	artery	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
.	.	.	O	O

8/20/07	8/20/07	CD	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
,	,	,	O	O
overall	overall	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
is	be	VBZ	B-VP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
thrombus	thrombus	NN	I-NP	O
detected	detect	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
root	root	NN	I-NP	O
size	size	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
embolus	embolus	NN	B-NP	O
identified	identify	VBN	B-VP	O
and	and	CC	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
prior	prior	JJ	B-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
4/18/07	4/18/07	CD	B-NP	O
and	and	CC	I-NP	O
10/6/07	10/6/07	CD	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Mundhenk	Mundhenk	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
severe	severe	JJ	B-NP	O
vasculopathy	vasculopathy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
carotid	carotid	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
8/4	8/4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
strokes	stroke	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
unresponsiveness	unresponsiveness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
here	here	RB	B-ADVP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
kidney	kidney	NN	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
nitro	nitro	NN	I-NP	O
paste	paste	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
minoxidil	minoxidil	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
stopped	stop	VBN	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
clonidine	clonidine	NN	B-NP	O
0.2	0.2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
and	and	CC	O	O
Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
stopped	stop	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
and	and	CC	I-NP	O
labetalol	labetalol	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
antihypertensives	antihypertensive	NNS	I-NP	O
include	include	VBP	B-VP	O
labetalol	labetalol	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
8	8	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
clonidine	clonidine	NN	I-NP	O
0.2	0.2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
receive	receive	VB	B-VP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
their	their	PRP$	B-NP	O
scheduled	scheduled	JJ	I-NP	O
times	time	NNS	I-NP	O
or	or	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
will	will	MD	B-VP	O
rise	rise	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
and	and	CC	O	O
as	as	IN	B-SBAR	O
detailed	detail	VBN	B-VP	O
above	above	IN	B-PP	O
carotid	carotid	NN	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
tight	tight	JJ	I-NP	O
right	right	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
1/21/07	1/21/07	CD	B-NP	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	I-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
cared	care	VBN	I-VP	O
for	for	IN	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Vascular	Vascular	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	JJ	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
Nephrology	Nephrology	NNP	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
intervention	intervention	NN	B-NP	O
regarding	regard	VBG	B-VP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
or	or	CC	O	O
visualization	visualization	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
kidneys	kidney	NNS	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
agreed	agree	VBD	B-VP	O
with	with	IN	B-PP	O
holding	hold	VBG	B-VP	O
the	the	DT	B-NP	O
furosemide	furosemide	NN	I-NP	O
and	and	CC	O	O
changing	change	VBG	B-VP	O
Lopressor	Lopressor	NN	B-NP	O
to	to	TO	B-PP	O
labetalol	labetalol	NN	B-NP	O
and	and	CC	O	O
titrating	titrate	VBG	B-VP	O
up	up	RP	B-PRT	O
labetalol	labetalol	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
clonidine	clonidine	NN	I-NP	O
could	could	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
0.1	0.1	CD	B-NP	O
mg	mg	NN	I-NP	O
increments	increment	NNS	I-NP	O
should	should	MD	O	O
she	she	PRP	B-NP	O
need	need	VB	B-VP	O
more	more	JJR	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
higher	high	JJR	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
labetalol	labetalol	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
2.6	2.6	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
has	have	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
2.6	2.6	CD	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
improved	improve	VBN	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
;	;	:	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
and	and	CC	O	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
including	include	VBG	B-PP	O
NPH	NPH	NN	B-NP	B-protein
and	and	CC	I-NP	O
AC	AC	NN	I-NP	O
coverage	coverage	NN	I-NP	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
6.4	6.4	CD	B-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

CONTACT	CONTACT	NN	B-NP	O
NUMBERS	NUMBERS	NNS	I-NP	O
:	:	:	O	O
Contact	Contact	NN	B-NP	O
numbers	number	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
members	member	NNS	I-NP	O
are	be	VBP	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Healthcare	Healthcare	NNP	B-NP	O
proxy	proxy	NN	I-NP	O
,	,	,	O	O
daughter	daughter	NN	B-NP	O
Rickey	Rickey	NNP	I-NP	O
Exantus	Exantus	NNP	I-NP	O
,	,	,	O	O
694-426-8874	694-426-8874	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Daughter	Daughter	NNP	B-NP	O
,	,	,	O	O
Orville	Orville	NNP	B-NP	O
Leyba	Leyba	NNP	I-NP	O
,	,	,	O	O
541-399-5592	541-399-5592	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Son	Son	NNP	B-NP	O
,	,	,	O	O
Isidro	Isidro	NNP	B-NP	O
Zangl	Zangl	NNP	I-NP	O
,	,	,	O	O
536-774-3603	536-774-3603	CD	B-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
dictated	dictate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
covering	cover	VBG	I-NP	O
team	team	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-9775836	0-9775836	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
WHIPP	WHIPP	NNP	B-NP	O
,	,	,	O	O
LESLIE	LESLIE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LAIGO	LAIGO	NN	B-NP	B-protein
,	,	,	O	O
PIERRE	PIERRE	NN	B-NP	O
Dictation	Dictation	NN	I-NP	O
ID	ID	NN	I-NP	O
3946688	3946688	CD	I-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
9/18/07	9/18/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/18/07	9/18/07	CD	B-NP	O

